> Rosetta Genomics is expanding its U.S. operations. Release
> DOV Pharmaceutical announced Phase Ib results for DOV 21,947, its lead triple reuptake inhibitor for the treatment of depression and obesity. Release
> Pfizer is paring down its Ann Arbor campus. FiercePharma
> New insights into the way the brain operates are opening up a new therapeutic target to control fever as well as many of its symptoms like fatigue and loss of appetite. FierceBioResearcher
And Finally... J&J is suing the Red Cross. FiercePharma